Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus

Christian Probst, Wolfgang Schlumberger, Winfried Stöcker, Andreas Recke, Enno Schmidt, Takashi Hashimoto, Xue Jun Zhu, Detlef Zillikens, Lars Komorowski

Abstract

INTRODUCTION: In paraneoplastic pemphigus (PNP), indirect immunofluorescence microscopy using rat bladder sections is widely used to search for circulating autoantibodies which are predominantly directed against envoplakin and periplakin. A sensitive and specific detection system for envoplakin/periplakin-specific autoantibodies is not yet available.

METHODS: Overlapping fragments spanning envoplakin and periplakin, respectively, were analyzed for their ability to bind PNP-specific autoantibodies by immunoblotting and ELISA in sera from patients with PNP (n=31), pemphigus vulgaris (n=30), and bullous pemphigoid (n=50) as well as healthy volunteers (n=140). The results were compared with those obtained by immunoblotting of extract of cultured human keratinocytes.

RESULTS: Immunoblot analysis revealed that most sera contained antibodies against the N-termini of both plakins as well as against the C-terminus of envoplakin. By ELISA, reactivities against envoplakin(1-481), envoplakin(1626-2033), and periplakin(1-324) were found in 25 (80.6%), 25 (80.6%), and 23 (74.2%) PNP sera, and in 1 (1.2%), 3 (3.7%), and 2 (2.5%) control sera, respectively.

CONCLUSIONS: The new ELISA based on an N-terminal fragment of envoplakin shows a high diagnostic accuracy to detect circulating autoantibodies in PNP. It is easy to be setup and standardized and can help to differentiate PNP patients from those with pemphigus vulgaris.

OriginalspracheEnglisch
ZeitschriftClinica Chimica Acta
Jahrgang410
Ausgabenummer1-2
Seiten (von - bis)13-8
Seitenumfang6
ISSN0009-8981
DOIs
PublikationsstatusVeröffentlicht - 2009

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren